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Severe hyperammonemia can occur as a result of inherited or acquired liver enzyme defects in the urea cycle, among which orni-
thine transcarbamylase deficiency (OTCD) is the most common form. We report a very rare case of a 45-year-old Korean male who 
was admitted to the intensive care unit (ICU) due to severe septic shock with acute respiratory failure caused by Pneumocystis jiroveci 
pneumonia. During his ICU stay with ventilator care, the patient suffered from marked hyperammonemia (>1,700 µg/dL) with abrupt 
mental change leading to life-threatening cerebral edema. Despite every effort including continuous renal replacement therapy and 
use of a molecular adsorbent recirculating system (extracorporeal liver support–albumin dialysis) to lower his serum ammonia level, 
the patient was not recovered. The lethal hyperammonemia in the patient was later proven to be a manifestation of acquired liver 
enzyme defect known as OTCD, which is triggered by serious catabolic conditions, such as severe septic shock with acute respiratory 
failure.
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■ Case Report ■
Patients with acute hyperammonemia are frequently encountered in the intensive care unit (ICU) and are known to have se-
rious morbidity and mortality. If the arterial ammonia level exceeds 200 µmol/L, cerebral edema and brain herniation can oc-
cur as brain astrocytes rapidly metabolize ammonia to glutamine, with a subsequent rise in intracellular osmolarity leading to 
astrocyte swelling and loss.[1-3]  
The causes of hyperammonemia can be divided into two main processes that either increase ammonia production or decrease 
ammonia elimination. Conditions that increase ammonia production include infection and protein load or increased catabolism 
such as severe exercise, seizure, trauma, starvation, gastrointestinal (GI) hemorrhage, steroid treatment, and chemotherapy, 
while conditions associated with decreased ammonia elimination comprise acute or chronic liver failure, portosystemic shunt, 
and various kinds of drugs. Among these conditions, fulminant hepatic failure is the most common cause of acute hyperam-
monemia in adult ICUs.[4]
 However, if the above-mentioned causes can be eliminated 
and the etiology of hyperammonemia continues to remain 
elusive with serum ammonia levels disproportionate to the 
degree of liver function, clinicians should suspect an inborn 
error of metabolism: urea cycle defect (UCD). As ammo-
nia is metabolized to urea through the urea cycle by several 
enzymes located mainly in the liver, inborn defects of such 
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enzymes can bring about severe, fatal hyperammonemia 
even in adulthood, among which ornithine transcarbamylase 
deficiency (OTCD) is most commonly diagnosed in adults.
[4-5]
We report a very rare case of a 45-year-old Korean male 
who developed lethal hyperammonemia with life-threaten-
ing cerebral edema resulting from adult-onset OTCD, which 
was triggered by severe septic shock with acute respiratory 
failure due to Pneumocystis jiroveci pneumonia during an 
ICU stay.
Case Report
A 45-year-old Korean male was admitted to our emergen-
cy room (ER) with dyspnea aggravation from 1 day prior. 
He had complained of coughing with dyspnea for 3 weeks. 
On arrival, his vital signs showed a mild fever of up to 
37.3°C, tachycardia (142 beats/min), and peripheral blood 
O2 saturation (SpO2) of 88% in room air. His past medical 
history included liver cirrhosis and chronic hepatitis B from 
6 years prior. About 1.5 years prior, he was diagnosed with 
hepatocellular carcinoma (HCC) and received trans-catheter 
arterial chemoembolization (TACE) and radiation therapy. 
After that, his liver function deteriorated continuously, lead-
ing to hepatic failure, and he underwent liver transplanta-
tion in China about 1 year prior. However, 7 months prior, 
regular follow-up imaging showed recurrence of HCC and 
multiple seeding nodules in the abdomen. Thereafter, five 
additional TACEs were performed with continuous adminis-
tration of immunosuppressants. 
At ER admission, chest imaging revealed patch consolida-
tions, ground glass opacities, and interlobular septal thick-
ening in both lungs, with bilateral pleural effusion (Fig. 1). 
His initial laboratory exam showed neutrophil counts of 
570/µL and slightly elevated C-reactive protein (15.7 mg/
dL) and serum creatinine levels (1.56 mg/dL) on a normal 
liver function test (Table 1). He was diagnosed with pneu-
monia in a neutropenic state. Despite full coverage of prop-
er antibiotics, his condition worsened steadily, eventually 
leading to acute respiratory failure and septic shock, which 
required ventilator care and hemodynamic monitoring in the 
ICU (hospital day 10). 
Bronchial washing cytology with Gomori methenamine 
silver staining confirmed the diagnosis of Pneumocystis 
jiroveci pneumonia. Furthermore, blood cultures proved 
to be positive for G(-) rods and G(+) cocci (hospital day 
24). In the meantime, he additionally experienced recurrent 
duodenal ulcer bleeding with an impending perforation, and 
endoscopic hemostasis was carried out repeatedly. With the 
passage of time, his general status was constantly aggra-
vated, and every effort to wean him off of treatment was not 
Fig. 1. Chest imaging (A, B) at admission shows bilateral patch consolidations, ground glass opacities and interlobular septal thickening 
with a small quantity of pleural effusion.
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successful. At hospital day 41, he underwent abrupt mental 
change and showed seizure-like movements. On laboratory 
examination, his ammonia level was measured as 411 µg/
dL, despite normal liver function test results. Moreover, 
blood urea nitrogen and creatinine levels rose up to 72.2 
mg/dL and 3.02 mg/dL, respectively (Table 1). Further 
neurological exams including electroencephalography diag-
nosed his condition as metabolic encephalopathy with nega-
tive myoclonus. After intravenous phenytoin and midazolam 
infusion, the seizure-like motions subsided. 
At hospital day 43, further exams, such as Doppler ultra-
sonography, were conducted to evaluate transplanted liver 
graft function, which displayed normal findings in the liver 
parenchyma, bile duct, and portal and hepatic vein, includ-
ing normal Doppler findings. Therefore, under presump-
tive diagnosis of UCD as a cause of the markedly elevated 
hyperammonemia, we performed a serum amino acid assay 
and urine analysis in order to detect urea cycle metabolites 
(at hospital day 44). Meanwhile, in spite of frequent lactu-
lose enema, administration of oral sodium phenylbutyrate, 
and continuous renal replacement therapy (CRRT), his am-
monia level continually increased to more than 1,700 µg/
dL, and his mental status deteriorated even more than before 
(hospital day 44; Table 1).
Contrast brain magnetic resonance imaging revealed 
severe swelling of the brain and increased cortical and sub-
cortical gray matter signals suggesting severe hypoxic dam-
age with an impending state of tonsillar and trans-tentorial 
herniation (Fig. 2). With his family’s consent, a molecular 
adsorbent recirculating system (MARS, extracorporeal liver 
support–albumin dialysis) was applied twice to lower the 
serum ammonia level (hospital day 44, 45). Then, though 
the serum ammonia level decreased to 956 µg/dL, his men-
tal status did not recover, and the serum ammonia level be-
gan to rise again. At hospital day 48, his vital signs became 
unstable, and metabolic acidosis developed. Finally, he ex-
pired due to refractory shock at hospital day 52. Afterwards, 
markedly elevated excretion of orotic acid was found on a 
Table 1. Change in the levels of serum complete blood cell count, liver function test, serum BUN, creatinine, and ammonia 
ER admission Hospital day 41 Hospital day 44
Hemoglobin (g/dL) 11.2 8.5 8.8
White blood cell (/uL) 1,550 5,350 8,380
Platelet(/uL) 240,000 57,000 103,000
Bilirubin (mg/dL) 0.3 0.3 0.2
AST (IU/L) 22 45 19
ALT (IU/L) 18 36 13
PT (sec)/INR 12.2/1.03 14.1/1.19 16.6/1.39
BUN (mg/dL) 14.9 71.6 72.2
Creatinine (mg/dL) 1.56 1.88 3.02
Ammonia (µg/dL) 411 1,700
BUN: blood urea nitrogen, ER: emergency room, AST: alanine aminotransferase, AST:  aspartate aminotransferase, PT: prothrombin time, INR: international normalized 
ratio. 
Fig. 2. Contrast brain magnetic resonance imaging shows se-
vere brain swelling and increased cortical and subcortical gray 
matter signal changes suggesting hypoxic damage.
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previously performed urine collection analysis, which was a 
diagnostic finding of ornithine transcarbamylase deficiency 
(OTCD; Fig. 3).
Discussion
OTCD is the most common inherited disorder among 
UCDs. The ornithine transcarbamylase (OTC) gene is lo-
cated on the short arm of the X chromosome and is mainly 
expressed in the liver.[6-8] Patients with OTCD experience 
repeated hyperammonemic episodes, resulting in eventual 
central nervous system (CNS) damage. It is a rare disease 
with an incidence of about one in every 40,000–80,000 
births.[9] As OTCD is an X chromosome–linked disorder, 
clinical severity differs according to sex. While hemizygous 
males are usually severely affected during the neonatal pe-
riod, heterozygous females exhibit various enzymatic activi-
ties and clinical courses, ranging from neonatal-onset fatal 
disease to the absence of symptoms during their lifetime.
[10] However, even those who remain asymptomatic into 
their adult life are able to undergo occasional expressions of 
symptoms when precipitated by factors such as high protein 
intake, infection, trauma, surgery, childbirth, or other physi-
ological catabolic stresses.[11] In Korea, adult-onset OTCD 
is known to be very rare compared to child-onset diseases. 
In the present case report, the patient had a previously 
unhealthy liver with chronic hepatitis B, liver cirrhosis, and 
HCC. He might have also had recurrent episodes of hepatic 
encephalopathy resulting from mild hyperammonemia due 
to his decompensated liver function, though we could not 
identify relevant data in his medical chart. However, he had 
gone through a normal growth process, not experiencing 
seizures or other neurologic disorders before chronic liver 
disease developed. Additionally, he underwent success-
ful liver transplantation without any complication or graft 
failure. Even after HCC recurred in his transplanted graft, 
liver function was constantly normal, and he managed to get 
along without any problems until he suffered from Pneu-
mocystis jiroveci pneumonia. In addition, we confirmed 
through Doppler ultrasonography that his transplanted liver 
did not have any graft dysfunction or anatomical problem 
in the vessels or ducts except for the recurred HCCs in the 
parenchyma at the time of abrupt mental change in the ICU. 
Therefore, considering the disproportionately high levels of 
serum ammonia with life-threatening cerebral edema and all 
Fig. 3. Urine collection analysis displays urine orotic acid peak confirming the diagnosis of ornithine transcarbamylase deficiency (OTCD). 
OTCD: ornithine transcarbamylase deficiency.
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of the other evidence mentioned above, we suspected UCD 
as a cause of his hyperammonemia and further confirmed 
the diagnosis of OTCD based on the high urinary orotic acid 
levels. To the best of our knowledge, this is the first Korean 
case of acquired OTCD after liver transplantation, present-
ing as deadly hyperammonemia in the ICU.
In OTCD, plasma glutamine and alanine levels increase 
whereas citrulline decreases, resulting from the shortage of 
the second-passage enzyme ornithine transcarbamylase.[5] 
A markedly increased level of urine orotic acid is diagnostic 
of OTCD as in this case.
Symptoms of late-onset OTCD varies from nausea, mild 
irritability, and protein avoidance to more serious forms 
such as neuropsychiatric changes, seizures, coma, and even 
death, which are precipitated by episodes of physiologic 
stress or catabolism that can lead to hyperammonemia.[11] 
In this case, the patient experienced Pneumocystis jiroveci 
pneumonia and consecutive bacterial septic shock with 
long-lasting ventilator care. Furthermore, recurrent duode-
nal ulcer bleeding might also have been a possible trigger-
ing factor for the disastrous manifestation in this patient. 
The treatment for acute hyperammonemia due to OTCD 
encompasses not only decreasing intracranial pressure but 
also reducing the production of nitrogenous wastes and 
lowering the serum ammonia levels as quickly as possible. 
Concretely, this includes restricting dietary protein intake 
and facilitating the removal of ammonia via alternative 
pathwaysby the intake of oral sodium phenylbutyrate or 
sodium benzoate. Hemodialysis is also an effective means 
of lowering the serum ammonia level quickly, and recent 
guidelines recommend starting hemodialysis as early as 
possible, particularly if the serum ammonia level exceeds 
200 umol/L despite an unconfirmed diagnosis of OTCD.[12] 
According to one case report, the MARS (extracorporeal 
liver support–albumin dialysis) was successful in lowering 
dialysis-unresponsive hyperammonemia in a patient with 
acquired hepatic glutamine synthetase deficiency after liver 
transplantation.[13] In this case, the patient also received 
continuous CRRT and MARS. However, the patient was not 
recovered, as severe cerebral edema and hypoxic brain dam-
age had already developed. Other important treatments in-
volve eliminating factors that precipitate hyperammonemia 
as promptly as possible, such as infection, GI bleeding, or 
medications (allopurinol, valproic acid). Associated factors 
in this patient were uncontrolled infection in addition to GI 
bleeding. Failure to remove these factors might have been 
another important cause of defeat. Liver transplantation is 
the last therapeutic option when the diagnosis of OTCD is 
definitely confirmed and life-threatening hyperammonemic 
crisis cannot be resolved despite ongoing treatments, al-
though such a procedure may be accompanied by numerous 
complications.[11,14] Nonetheless, to prevent cognitive de-
fects and developmental delay as a consequence of recurrent 
hyperammonemic episodes, liver transplantation is worth 
consideration as early as possible for children, whereas 
adult-onset OTCD does not have any widely accepted con-
sensus regarding the indications or the best timing for liver 
transplantation.[9,14] 
In summary, we have reported a very rare and unique case 
of life-threatening hyperammonemia caused by adult-onset 
OTCD, triggered by severe septic shock with acute respira-
tory failure in an immunocompromised host. This case sug-
gests that if a patient presents with disproportionately high 
level of serum ammonia during ICU care and no apparent 
cause of hyperammonemia can be identified, intensivists 
should suspect an inborn error of metabolism such as UCD, 
and appropriate management should be started to lower the 
serum ammonia level as quickly as possible, even before the 
diagnosis is made.
 
ORCID
Moo Suk Park http://orcid.org/0000-0003-0820-7615  
References
  1) Gropman AL, Summar M, Leonard JV: Neurological 
implications of urea cycle disorders. J Inherit Metab 
Dis 2007; 30: 865-79.
  2) Shawcross D, Jalan R: The pathophysiologic basis of 
hepatic encephalopathy: central role for ammonia and 
inflammation. Cell Mol Life Sci 2005; 62: 2295-304.
  3) Vaquero J, Chung C, Cahill ME, Blei AT: Pathogenesis 
of hepatic encephalopathy in acute liver failure. Semin 
Liver Dis 2003; 23: 259-69.
  4) Clay AS, Hainline BE: Hyperammonemia in the ICU. 
http://dx.doi.org/10.4266/kjccm.2016.31.2.140
Ji An Hwang, et al. Lethal Hyperammonemia due to OTCD  145
Chest 2007; 132: 1368-78.
  5) Bachmann C: Inherited hyperammonemia. In: Physi-
cians Guide to the Laboratory Diagnosis of Metabolic 
Diseases. 2nd ed. Edited by Blau N, Duran M, Blaskov-
ics ME, Gibson KM: Berlin, Springer. 2003, pp 261-76.
  6) Brusilow SW, Horwich AL: Urea cycle enzymes. In: 
The Metabolic and Molecular and Bases of Inherited 
Disease, 4 volume. 8th ed. Edited by Scriver CR, Beau-
det AL, Valle D, Sly WS, Childs B, Kinzler KW, et al: 
New York, McGraw-Hill. 2000, pp 1909-61.
  7) Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuch-
man M: Mutations and polymorphisms in the human 
ornithine transcarbamylase (OTC) gene. Hum Mutat 
2006; 27: 626-32.
  8) Arranz JA, Riudor E, Marco-Marín C, Rubio V: Esti-
mation of the total number of disease-causing mutations 
in ornithine transcarbamylase (OTC) deficiency. Value 
of the OTC structure in predicting a mutation patho-
genic potential. J Inherit Metab Dis 2007; 30: 217-26.
  9) Wakiya T, Sanada Y, Mizuta K, Umehara M, Urahasi 
T, Egami S, et al: Living donor liver transplantation for 
ornithine transcarbamylase deficiency. Pediatr Trans-
plant2011; 15: 390-5.
10)  Yorifuji T, Muroi J, Uematsu A, Tanaka K, Kiwaki K, 
Endo F, et al: X-inactivation pattern in the liver of a 
manifesting female with ornithine transcarbamylase 
(OTC) deficiency. Clin Genet 1998; 54: 349-53.
11)  Gordon N: Ornithine transcarbamylase deficiency: a 
urea cycle defect. Eur J Paediatr Neurol 2003; 7: 115-
21.
12)  Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon 
M, Huemer M, et al: Suggested guidelines for the di-
agnosis and management of urea cycle disorders. Or-
phanet J Rare Dis 2012; 7: 32.
13)  Chiu A, Tam S, Au WY, Chan SC, Liu CL, Fan ST: 
MARS treatment for a patient presenting with acquired 
hepatic glutamine synthetase deficiency after orthotopic 
liver transplantation. Liver Transpl 2005; 11: 353-5.
14)  Busuttil AA, Goss JA, Seu P, Dulkanchainun TS, Yanni 
GS, McDiarmid SV, et al: The role of orthotopic liver 
transplantation in the treatment of ornithine transcarba-
mylase deficiency. Liver Transpl Surg 1998; 4: 350-4.
